European Pharma companies to disclose health professional payments

Diagnosis while pregnant should not lead to treatment delay or pregnancy termination

First ‘targeted’ treatment for small cell lung cancer shows promise

DDFMISO trial confirms significant negative prognostic value of tumour hypoxia

Results of a placebo­ controlled study of tasquinimod in men with metastatic castrate resistant prostate cancer

Brain metastases genomic analysis could reveal new targets for treatment

'Survivor passport' for survivors of childhood leukaemia

Hodgkin lymphoma incidence in young affected by social deprivation, gender

Progression of childhood cancers in Europe

HPV vaccines for cancer prevention

Is it possible to develop cancer drugs at a lower cost?

Examining NSCLC responses to durvalumab monotherapy